Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
UnitedHealth (UNH) sold off sharply after weaker-than-expected Medicare guidance and a conservative 2026 revenue outlook. The pullback leaves a high-quality healthcare franchise trading on reasonable multiples, supported by roughly $17.4B of free cash flow, strong returns on equity, and a solid balance sheet. This trade idea lays out an actionable …
First Financial (THFF) is trading near fresh 52-week highs after a steady cadence of dividends, a small acquisition and consistent profitability. At roughly a $825M market cap, the bank screens cheap on P/E and P/B versus broad regional bank norms, and technical momentum supports a continuation higher. This trade idea lays out a mid-term (45 tradin…
President Donald Trump told NBC News he sees "not much" doubt that the Federal Reserve will reduce benchmark U.S. interest rates. He also said his Fed nominee, Kevin Warsh, understands and aligns with his preference for monetary easing, and that support for rate cuts was a condition for the appointment.
Senate Banking Committee Chair Tim Scott said he does not believe Federal Reserve Chair Jerome Powell broke the law in testimony last summer and would tell investigators so. His comments constitute the first explicit rebuttal from the committee chair to a Department of Justice inquiry that has complicated President Trump’s plan to replace Powell wi…
Coherus Biosciences has agreed to provide clinical supply to Johnson & Johnson for a Phase 1b study combining JNJ’s pasritamig with Coherus’s anti-CCR8 antibody tagmokitug in metastatic castration-resistant prostate cancer. Oppenheimer reiterated an Outperform rating and a $10 price target on Coherus, while InvestingPro data shows a broader analyst…
Meta is showing that AI can be a direct revenue engine, not just a research headline. Strong free cash flow ($46.1B implied), a high ROE (27.8%), and an ad platform that reaches billions give Meta an edge over enterprise-centric rivals when it comes to monetizing AI. This trade idea lays out an actionable long: entry $675, stop $640, target $840 ov…
Leerink affirmed an Outperform rating on Cencora (COR) and maintained a $410 price target, shifting its valuation basis from roughly 22.5x CY26 earnings to about 20x CY27 earnings. The firm pointed to a roughly 350 basis point beat on U.S. Healthcare AOI, robust revenue growth and a strong one-year stock return as supporting evidence for continued …
The U.S. Supreme Court on Wednesday declined to block California’s recently redrawn congressional map, allowing a map approved by state voters last year that is expected to add five seats favorable to Democrats. The court issued a one-sentence order denying the California Republican Party’s emergency request without public dissent or explanation. T…
Earnings season continues on Thursday, February 5, 2026, with a long roster of companies scheduled to report results either before the market opens or after it closes. High-profile names that will draw particular attention include Amazon, Fortinet, Microchip Technology, Roblox and Atlassian. The combined slate spans technology, retail, industrials,…
A set of labor-market indicators due Thursday, including the weekly initial jobless claims and the monthly JOLTs job openings report, will offer fresh readings on U.S. employment. Additional releases covering continuing claims, the Fed's balance sheet and reserve balances, Treasury bill auctions, and natural gas storage will add to market-moving in…
Short sellers have recorded roughly $24 billion in unrealized gains as a focused decline in software and AI-linked equities accelerates. Data from S3 Partners LLC show rising short interest across major technology names, with market participants citing worries that rapid AI advances could undercut traditional software revenue models.
Morgan Stanley raised its price target on Evercore Partners to $381 from $376 while retaining an Equalweight rating. The firm increased its 2026 and 2027 EPS forecasts modestly, citing higher projected advisory, underwriting, commission and investment management revenues, offset in part by rising expenses. Evercore recently posted stronger-than-exp…
Wolfe Research held an Outperform rating and a $235.00 price target on RTX following a framework agreement to expand missile production under a Pentagon initiative to bolster defense industrial capacity. The firm estimated the build-out could add roughly $7-8 billion in revenue to RTX’s Raytheon segment and noted effects on growth assumptions and c…
Raymond James cut its rating on Lumen Technologies to Market Perform from Outperform, arguing that the material gains from recent deleveraging are largely captured and that the company must now deliver a return to revenue growth. The firm highlights a strengthened balance sheet following a fiber sale, but warns of execution risks and uncertain near…
Raymond James raised its price objective on Flex Ltd to $80 from $75 and retained an Outperform rating after the company reported December-quarter results. The firm pointed to strength in high-performance networking and communications within Flex’s CEC segment and expects further clarity on cloud and AI growth drivers when reporting segments are re…
Oil prices climbed sharply after reports indicated planned talks between the United States and Iran were at risk of collapsing over disagreement on the meeting format and location. U.S. crude rose about 3.5% to above $65.30 a barrel and Brent gained roughly 3.4% to $69.60 a barrel as of mid-afternoon ET. The reported impasse follows heightened tens…
The U.S. Justice Department has pulled a Department of Homeland Security attorney off an assignment in Minnesota after she declared during a federal court hearing that "this job sucks" and said immigration authorities had not consistently followed judicial orders. The lawyer, Julie Le, had been working at the U.S. Attorney’s Office in St. Paul to a…
A Deutsche Bank review shows that, even as investors rotate away from many technology and software companies amid AI-driven disruption concerns, the group of seven largest tech names has held the broader market near record levels. Software stocks have suffered sharp drops, but gains concentrated in Alphabet have offset much of the pain across the m…
Wolfe Research upgraded Fabrinet to Outperform, arguing the contract optical manufacturer stands to gain from rising data-center demand and industry-wide supply limitations. The brokerage flagged recent share weakness as excessive, highlighted capacity expansion plans as a clearer forward indicator of revenue, and raised its price target to $540 wh…
Bitcoin fell to about $72,000, its weakest level in 15 months, as a market-wide decline pushed investors to liquidate positions. The cryptocurrency dropped as much as 5.4%, extending losses from earlier, crypto-focused liquidations and coinciding with a broader pullback in global equities, including a more than 2% slide in the Nasdaq 100 that hit s…
BTIG raised its price target on GE HealthCare to $91 from $87 and kept a Buy rating after the medical-device maker reported fourth-quarter 2025 results that beat both BTIG and consensus estimates for revenue and adjusted earnings per share. Management provided fiscal 2026 guidance showing modest organic revenue growth, margin expansion and higher a…
Deutsche Bank maintained a Buy rating and a $1,200.00 price target on Eli Lilly after the company provided fiscal 2026 guidance above consensus and reported fourth-quarter 2025 results that exceeded expectations. Lilly forecast FY26 revenue of $80-$83 billion and non-GAAP EPS of $33.50-$35.00, and reported Q4 revenue and EPS that outpaced Street fo…
BofA Securities has kept an Underperform rating on Amgen with a $304 price target while the stock trades around $366.10 and close to its 52-week high. InvestingPro data indicates the shares are roughly fairly valued at current levels. The bank pointed to a series of pipeline catalysts stretching from 2026 into 2027 that will shape the company’s out…
Idaho Strategic Resources (IDR) has pulled back to $37.43 after a sharp run, offering an actionable long entry. Fundamentals show profitability, low debt, and growing free cash flow; technicals are tired but short interest and elevated volumes set the stage for a momentum retest. Our trade plan buys the dip with a clear stop and a target at the 52-…
U.S. equity markets fell sharply Wednesday as a renewed round of selling hit technology stocks, with software names plunging early in the session and weakness rotating into semiconductor and memory companies. The NASDAQ Composite dropped 2.2% as investors reacted to mounting concerns that rapid advances in artificial intelligence are disrupting par…
